Literature DB >> 12514440

Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics.

Barbara Romanowski1, Jutta Preiksaitis, Patricia Campbell, Jayne Fenton.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) is a major global problem, transmitted primarily by percutaneous exposure to contaminated blood. GOAL: The goal of the study was to determine the seroprevalence of and risk factors for HCV among patients attending two urban STD clinics in Alberta. STUDY
DESIGN: Anonymous unlinked serosurveys were performed with use of leftover sera. Self-administered questionnaires collected information on demographics, sexual behaviors, and drug use.
RESULTS: The seroprevalence of HCV was 3.4% (209 of 6,668 patients). Univariate analysis revealed that infection was higher among nontherapeutic needle users (RR = 80.9), those coinfected with HIV (RR = 8.09), individuals over the age of 20 years (RR = 6.68), those of aboriginal ethnicity (RR = 5.54), those with a history of STD (RR = 3.43), men (RR = 2.2), and bisexuals (RR = 2.23). Not utilizing condoms and engaging in prostitution or exchanging money or drugs for sex were also risk factors. In multivariate analysis, nontherapeutic needle use remained highly significant (RR = 60.54-65.51). Other significant factors included sex, age, ethnicity, a history of STD, and HIV infection (RR = 1.72, 4.62, 3.18, 1.69, and 2.56, respectively). Sexual orientation and sexual practices were not significant without a history of drug use.
CONCLUSION: Nontherapeutic needle use is the strongest predictor of HCV infection.

Entities:  

Mesh:

Year:  2003        PMID: 12514440     DOI: 10.1097/00007435-200301000-00008

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  10 in total

1.  [Increase in syphilis and STD coinfections in HIV-infected individuals in Dresden].

Authors:  P Spornraft-Ragaller; M Meurer
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

2.  Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.

Authors:  Juan C Reyes; Héctor M Colón; Rafael R Robles; Eddy Rios; Tomás D Matos; Juan Negrón; Carmen Amalia Marrero; José M Calderón; Elizabeth Shepard
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

Review 3.  Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Authors:  Todd H Driver; Norah Terrault; Varun Saxena
Journal:  J Gen Intern Med       Date:  2012-11-14       Impact factor: 5.128

4.  Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Authors:  Benedikt Fischer; Emma Haydon; Jürgen Rehm; Mel Krajden; Jens Reimer
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

5.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

6.  Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals.

Authors:  Kathleen A Brady; Mark Weiner; Barbara J Turner
Journal:  J Infect       Date:  2009-05-03       Impact factor: 6.072

7.  Public health clinic-based hepatitis C testing and linkage to care in Baltimore.

Authors:  O Falade-Nwulia; S H Mehta; J Lasola; C Latkin; A Niculescu; C O'Connor; P Chaulk; K Ghanem; K R Page; M S Sulkowski; D L Thomas
Journal:  J Viral Hepat       Date:  2016-02-03       Impact factor: 3.728

Review 8.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

9.  Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART.

Authors:  Viviane D Lima; Patricia Kretz; Anita Palepu; Simon Bonner; Thomas Kerr; David Moore; Mark Daniel; Julio S G Montaner; Robert S Hogg
Journal:  AIDS Res Ther       Date:  2006-05-24       Impact factor: 2.250

10.  Predictors of Frequent Emergency Room Visits among a Homeless Population.

Authors:  Kinna Thakarar; Jake R Morgan; Jessie M Gaeta; Carole Hohl; Mari-Lynn Drainoni
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.